Výsledky vyhledávání

Akademický článek

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Autor: DE Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Nogueira BMD; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Barreto IV; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DA Costa Machado AK; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Gadelha RB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Sousa Oliveira D; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Silva FAC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Gurgel LA; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Medeiros JC; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., DA Rocha Maciel A; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza, CE, Brazil., Vieira RPG; Department of Hematology, São Vicente de Paulo Maternity Hospital, Barbalha, CE, Brazil., DE Moraes Filho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil; carolfam@gmail.com.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil.; Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.

Publikováno v: In vivo (Athens, Greece) [In Vivo] 2024 Jul-Aug; Vol. 38 (4), pp. 2016-2023.

Zobrazit plný text záznamu

Akademický článek

Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

Autor: DA Costa Machado AK; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Machado CB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Pinho Pessoa FMC; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Barreto IV; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Gadelha RB; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Sousa Oliveira D; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Ribeiro RM; Department of Hematology, Fortaleza General Hospital (HGF), Fortaleza, CE, Brazil., Lopes GS; Department of Hematology, César Cals General Hospital, Fortaleza, CE, Brazil., DE Moraesfilho MO; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., DE Moraes MEA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil., Khayat AS; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil., Moreira-Nunes CA; Department of Medicine, Pharmacogenetics Laboratory, Drug Research and Development Center (NPDM), Federal University of Ceará, Fortaleza, CE, Brazil.; Department of Biological Sciences, Oncology Research Center, Federal University of Pará, Belém, PA, Brazil.; Clementino Fraga Group, Central Unity, Molecular Biology Laboratory, Fortaleza, CE, Brazil.

Publikováno v: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2024 Jan 03; Vol. 4 (1), pp. 9-24. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2024).

Zobrazit plný text záznamu